Uniportal and triportal video-assisted thoracoscopic lobectomy for treatment of non-small cell lung cancer: a comparative study
10.3969/j.issn.1007-1989.2017.09.011
- VernacularTitle:单孔与三孔胸腔镜下肺叶切除术治疗非小细胞肺癌的临床疗效对比
- Author:
Wang KUN
1
;
Wang LIN
;
Wang WEI
;
Sun TAO
;
Li WEI
;
Song HUAN
;
Hu XU
Author Information
1. 安徽省亳州市人民医院 胸外科
- Keywords:
uniportal surgery;
video-assisted thoracoscopic surgery;
lobectomy;
non-small cell lung cancer
- From:
China Journal of Endoscopy
2017;23(9):59-63
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical effects of uniportal and triportal video-assisted thoracoscopic lobectomy in treatment of non-small cell lung cancer. Methods From January 2013 to November 2016, 141 non-small cell lung cancer patients underwent uniportal video-assisted thoracoscopic lobectomy (52 cases, uniportal group), and 89 lung cancer patients underwent triportal video-assisted thoracoscopic lobectomy (triportal group). All the cases were performed by the same surgeon. The operative time, intraoperative blood loss, lymph node dissection number, chest drainage duration, postoperative total drainage volume, hospital stay and postoperative complications were recorded and compared between the two groups. Results There were no statistical differences in lymph node dissection number, chest drainage duration, postoperative total drainage volume and postoperative complications after surgery between the uniportal group and the triportal group (P > 0.05). The mean operative time for the uniportal group and the triportal group was (196.1 ± 19.6) minutes and (162.7 ± 18.9) minutes, respectively, P = 0.000. The mean intraoperative blood loss for the uniportal group and the triportal group was (100.3 ± 13.6) ml and (176.5 ± 15.9) ml, respectively, P = 0.000. The hospital stay for the uniportal group and the triportal group was (7.5 ± 1.7) days and (9.2 ± 1.3) days, P = 0.000. Conclusion Uniportal video-assisted thoracoscopic lobectomy can achieve the same effect as triportal video-assisted thoracoscopic lobectomy, though it increased the operation time, however, it has the advantage of less surgical damage to chest wall muscles, intercostal nerves or blood vessels, shorten the postoperative hospital stay, and can be used as a safe and reliable radical surgery for non-small cell lung cancer.
